Skip to main content
ConductScienceScienceDex

M Javad Aman

NIH Rank #3064
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 2257929Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2025

Linked Award Amount
$3.2M
Full award amounts, FY2025
Award Records
4
Records listing this PI
Award-Linked Rank
#3,064
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for M Javad Aman. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing M Javad Aman as a PI. Multi-PI records show the full award amount for context.

  • 4R44AI179371-02R44
    Monoclonal Antibody Cocktail for Treatment of Marburg Virus Disease
    Abvacc, Inc.
    $1M
    award amount
  • 5R44AI177045-03R44
    Prophylactic Immunotherapy for Marburg Virus Disease Outbreak Control
    Abvacc, Inc.
    $914.8K
    award amount
  • 5R01AI111205-09R01
    Multivalent Toxoid Vaccine for recurrent Staphylococccus aureus disease
    Abvacc, Inc.
    $646.1K
    award amount
  • 1R01AI193221-01R01
    A multimodal approach for immunotherapy of Staphylococcus aureus bacteremia
    Abvacc, Inc.
    $639K
    award amount

Award organization

Organizations that administered FY2025 awards listing M Javad Aman as a PI.

FY2025 award administered by Abvacc, Inc. (MD).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Abvacc, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #4570
  6. 2024
    Entered Top 25% Nationally
    Ranked #4570
  7. 2025
    $5M Cumulative Funding
  8. 2025
    R01 Grant Holder

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as M Javad Aman.

Thomas William Geisbert
Abvacc, Inc.
2
shared awards
Nathan K. Archer
Abvacc, Inc.
1
shared award

Explore further

Find collaborators for M Javad Aman

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →